Temozolomide Is Effective and Well Tolerated in Patients with Primary Vitreoretinal Lymphoma - Sorbonne Université Access content directly
Journal Articles Blood Year : 2020

Temozolomide Is Effective and Well Tolerated in Patients with Primary Vitreoretinal Lymphoma

Marion Blaizeau
  • Function : Author
Pierre Soubeyran

Abstract

No abstract available

Dates and versions

hal-03892136 , version 1 (09-12-2022)

Identifiers

Cite

Marine Baron, Lisa Belin, Nathalie Cassoux, Christine Fardeau, Marion Blaizeau, et al.. Temozolomide Is Effective and Well Tolerated in Patients with Primary Vitreoretinal Lymphoma. Blood, 2020, 135 (20), pp.1811--1815. ⟨10.1182/blood.2019003073⟩. ⟨hal-03892136⟩
14 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More